Source: BioSpace

BIDMC: CND Life Sciences Enters into Licensing and Collaboration Agreement to Advance Diagnostic Technology for Neurodegenerative Diseases

CND Life Sciences has entered into a licensing collaboration with Beth Israel Deaconess Medical Center (BIDMC) in Boston to advance CND's scientific platform and patient-focused mission.

Read full article »
Est. Annual Revenue
$3.1B
Est. Employees
35,000
Kevin Tabb's photo - President & CEO of BIDMC

President & CEO

Kevin Tabb

CEO Approval Rating

72/100

Read more